arrow
付

付慧 (Hui Fu)

department of neonatology
H指数:20
被引数:1,544

个人简介

2007年9月至2011年7月于河北农业大学生命科学学院生物技术专业获理学学士学位,2011年9月至2016年7月于天津医科大学肿瘤医院肿瘤学专业获医学博士学位。

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial

既往接受过曲妥珠单抗辅助和/或新辅助治疗的患者中,吡托替尼联合白蛋白结合型紫杉醇一线治疗HER2-positive转移性乳腺癌的疗效和安全性: 单臂2期前瞻性临床试验的1期结果

2024-05-130
OAAI
Efficacy, safety and translational study of pyrotinib combined with albuminbound paclitaxel as firstline treatment of HER-2 positive metastatic breast cancer
2024-05-020
PRE
Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): preliminary results of a single-arm, multicenter phase II trial
2024-05-020
PRE